Investigating epigenetic therapies and combinations for the treatment of cancersShane W. O’Brien(Millersville University)UnknownJanuary 1, 202310.17760/d20620610Cited by 1SaveCiteExport RISWatch citationsRelated PapersInhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer|BMC Cancer|2023|32